Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
[ Tue, Aug 28th 2012 ] - Market Wire
KWG Files for Aggregate Permits
[ Tue, Aug 28th 2012 ] - Market Wire
Lapse of Options
Mon, August 27, 2012
[ Mon, Aug 27th 2012 ] - Market Wire
U3O8 Corp. Graduates to the TSX
Sun, August 26, 2012
[ Sun, Aug 26th 2012 ] - Market Wire
Geitungen is an Oil Discovery
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Market Activity
Tue, August 21, 2012

Andrew Peters Downgraded (BMRN) to Hold and Held Target at $45 on, Aug 27th, 2012


//stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-45-on-aug-27th-2012.html
Published in Stocks and Investing on by   Print publication without navigation


Andrew Peters of Deutsche Bank, Downgraded "BioMarin Pharmaceutical Inc." (BMRN) to Hold and Held Target at $45 on, Aug 27th, 2012.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Gena Wang of "Barclays" Initiated at Buy and Held Target at $46 on, Friday, August 24th, 2012
  • Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012